Nayla Majeda Alfarafisa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Circulating Tumor

Top Venues

Advances and applications in bioinformatics and chemistry : AABC

Clinical, cosmetic and investigational dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hesti Lina Wiraswati, Muhammad Hasan Bashari, Nayla Majeda Alfarafisa, Ilma Fauziah Ma'ruf, Eti Nurwening Sholikhah, Tutik Dwi Wahyuningsih, Pamungkas Bagus Satriyo, Mustofa Mustofa, Denny Satria, Ema Damayanti
Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study. Advances and applications in bioinformatics and chemistry : AABC 17 (2024)
Hesti Lina Wiraswati, Muhammad Hasan Bashari, Nayla Majeda Alfarafisa, Ilma Fauziah Ma'ruf, Eti Nurwening Sholikhah, Tutik Dwi Wahyuningsih, Pamungkas Bagus Satriyo, Mustofa Mustofa, Denny Satria, Ema Damayanti
Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study. Advances and applications in bioinformatics and chemistry : AABC 17 (2024)
Yoan Chou, Nayla Majeda Alfarafisa, Maiko Ikezawa, Astrid Feinisa Khairani
Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging. Clinical, cosmetic and investigational dermatology 16 (2023)
Marselina Irasonia Tan, Nayla Majeda Alfarafisa, Popi Septiani, Anggraini Barlian, Mochamad Firmansyah, Ahmad Faizal, Lili Melani, Husna Nugrahapraja
Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 11 (15) (2022)